Washington Capital Management Inc. Trims Stake in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Washington Capital Management Inc. decreased its position in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) by 11.8% during the first quarter, Holdings Channel reports. The fund owned 7,500 shares of the company’s stock after selling 1,000 shares during the period. Washington Capital Management Inc.’s holdings in Prestige Consumer Healthcare were worth $645,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in the company. Kestra Investment Management LLC purchased a new stake in shares of Prestige Consumer Healthcare in the 4th quarter worth approximately $27,000. CIBC Private Wealth Group LLC raised its holdings in Prestige Consumer Healthcare by 48.9% in the 4th quarter. CIBC Private Wealth Group LLC now owns 463 shares of the company’s stock worth $34,000 after purchasing an additional 152 shares during the period. Headlands Technologies LLC bought a new position in Prestige Consumer Healthcare in the 4th quarter worth $40,000. McIlrath & Eck LLC raised its holdings in Prestige Consumer Healthcare by 19.1% during the fourth quarter. McIlrath & Eck LLC now owns 959 shares of the company’s stock valued at $75,000 after acquiring an additional 154 shares during the period. Finally, Johnson Financial Group Inc. bought a new stake in Prestige Consumer Healthcare during the fourth quarter valued at about $93,000. Hedge funds and other institutional investors own 99.95% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms have commented on PBH. Oppenheimer raised their price target on Prestige Consumer Healthcare from $87.00 to $93.00 and gave the company an “outperform” rating in a report on Thursday, February 13th. Royal Bank of Canada raised Prestige Consumer Healthcare to a “hold” rating in a report on Thursday, May 8th. Finally, Wall Street Zen raised Prestige Consumer Healthcare from a “hold” rating to a “buy” rating in a report on Saturday, May 17th. Three analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $93.33.

Insider Activity

In related news, SVP Mary Beth Fritz sold 1,678 shares of Prestige Consumer Healthcare stock in a transaction dated Monday, March 10th. The stock was sold at an average price of $90.00, for a total value of $151,020.00. Following the completion of the transaction, the senior vice president now owns 17,157 shares in the company, valued at approximately $1,544,130. This trade represents a 8.91% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Company insiders own 1.60% of the company’s stock.

Prestige Consumer Healthcare Trading Up 0.6%

Shares of Prestige Consumer Healthcare stock opened at $85.11 on Friday. The firm has a market cap of $4.21 billion, a price-to-earnings ratio of 19.93, a PEG ratio of 2.69 and a beta of 0.45. The business has a 50-day moving average price of $83.53 and a 200-day moving average price of $82.52. The company has a quick ratio of 2.20, a current ratio of 3.68 and a debt-to-equity ratio of 0.56. Prestige Consumer Healthcare Inc. has a twelve month low of $63.79 and a twelve month high of $90.04.

Prestige Consumer Healthcare (NYSE:PBH) last issued its quarterly earnings data on Thursday, May 8th. The company reported $1.32 earnings per share for the quarter, beating analysts’ consensus estimates of $1.30 by $0.02. The firm had revenue of $296.52 million during the quarter, compared to analyst estimates of $289.36 million. Prestige Consumer Healthcare had a return on equity of 12.36% and a net margin of 19.13%. The business’s quarterly revenue was up 7.0% compared to the same quarter last year. During the same quarter last year, the business posted $1.02 earnings per share. Equities research analysts anticipate that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current fiscal year.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.